We previously reported that IgM anti-PC is associated with protection in atherosclerosis progress among hypertensives12, CVD (including both stroke and MI)14–16, rheumatic diseases, especially SLE, and other systemic rheumatic diseases, but also RA6,17,18 and mortality in chronic kidney disease19. This evidence concerns the gene CD40LG and stroke disorder.